It is known that modulation of immune-cell phenotype and function in the CP acts as a “checkpoint” for peripheral immune cells invading into the central nervous system (CNS) in a variety of neurological diseases (Brendecke and Prinz, 2015; Goldmann et al., 2016). The gene discussed is CP; the disease is nervous system disorder.